Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis

Immune checkpoint inhibitor (ICI)-induced arthritis is an increasingly recognized adverse event in patients with oncologic disease during immunotherapy. Four patterns are well described, including rheumatoid arthritis (RA)-like, polymyalgia rheumatica (PMR)-like, psoriatic arthritis (PsA)-like, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponce, Andrés, Frade-Sosa, Beatriz, Sarmiento-Monroy, Juan C., Sapena, Nuria, Ramírez, Julio, Azuaga, Ana Belén, Morlà, Rosa, Ruiz-Esquide, Virginia, Cañete, Juan D., Sanmartí, Raimon, Gómez-Puerta, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406920/
https://www.ncbi.nlm.nih.gov/pubmed/36010310
http://dx.doi.org/10.3390/diagnostics12081961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406920/
https://www.ncbi.nlm.nih.gov/pubmed/36010310
http://dx.doi.org/10.3390/diagnostics12081961

Ejemplares similares